Jennison Associates’s Axonics, Inc. Common Stock AXNX Stock Holding History

Jennison Associates’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-354,331	Closed	-$22.1M	–	643
2023 Q4	$22.1M	Buy	354,331 +128,374	+57%	+$7.18M	0.02%	318
2023 Q3	$12.7M	Buy	225,957 +24,631	+12%	+$1.39M	0.01%	354
2023 Q2	$10.2M	Hold	201,326	–	–	0.01%	378
2023 Q1	$11M	Buy	201,326 +1,243	+0.6%	+$72.6K	0.01%	383
2022 Q4	$12.5M	Sell	200,083 -128,460	-39%	-$8.52M	0.01%	377
2022 Q3	$23.1M	Buy	328,543 +6,582	+2%	+$454K	0.02%	304
2022 Q2	$18.2M	Sell	321,961 -351,557	-52%	-$19.3M	0.02%	319
2022 Q1	$42.2M	Buy	673,518 +340,405	+102%	+$18.3M	0.03%	241
2021 Q4	$18.7M	Buy	333,113 +48,293	+17%	+$2.95M	0.01%	375
2021 Q3	$18.5M	Sell	284,820 -3,504	-1%	-$239K	0.01%	373
2021 Q2	$18.3M	Buy	+288,324	New	+$17M	0.01%	381

Other funds holding AXNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Jennison Associates's AXNX Position: Q1 2024 in Review

Jennison Associates sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2024, closing a stake of 354,331 shares — an estimated $22.1M sold.

Jennison Associates first reported a position in AXNX in Q2 2021 and held it in 11 quarters. The position peaked at $42.2M in Q1 2022. 235 funds tracked by Wall St. Rank hold AXNX as of Q1 2024.

Jennison Associates reported no remaining Axonics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Jennison Associates sold 354,331 Axonics, Inc. Common Stock shares in Q1 2024, an estimated $22.1M.
Jennison Associates first reported a position in Axonics, Inc. Common Stock in Q2 2021 and held it in 11 quarters.
Jennison Associates's Axonics, Inc. Common Stock position peaked at $42.2M in Q1 2022.
235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2024.

Based on Jennison Associates's 13F filing for Q1 2024, filed 2 May 2024.